Cargando…

Azithromycin/hydroxychloroquine: QT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602512/ http://dx.doi.org/10.1007/s40278-021-05562-4

Ejemplares similares

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor
por: Nakayama, Yui, et al.
Publicado: (2021)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
por: Eftekhar, Seyed Parsa, et al.
Publicado: (2021)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: Cardiac arrest following off-label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine: Non-sustained monomorphic ventricular tachycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Three cases of catecholaminergic polymorphic ventricular tachycardia with prolonged QT intervals including two cases of compound mutations
por: Saito, Aki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u4tou4ki1ijrluifmmvcskhb1n